Grekinis D, Reimann E M, Schlender K K
Department of Pharmacology, Medical College of Ohio, Toledo 43699, USA.
Int J Biochem Cell Biol. 1995 Jun;27(6):565-73. doi: 10.1016/1357-2725(95)00029-O.
The regulation of cardiac muscle glycogen metabolism is not well understood. Previous studies have indicated that heart glycogen synthase is heavily phosphorylated in vivo on multiple sites. Using purified enzymes, we have investigated the effect of phosphorylation of different sites on the activity of rat heart glycogen synthase. A convenient procedure was developed for the purification of rat heart glycogen synthase. The enzyme was phosphorylated by selected kinases, and glycogen synthase activity, extent of phosphorylation, and phosphopeptide maps were analyzed. Rat heart glycogen synthase, purified to apparent homogeneity (M(r) 87,000 on SDS-PAGE), had a specific activity of 18 U/mg protein and had an activity ratio of 0.74 (activity in the absence divided by the activity in the presence of glucose 6-P). cAMP-dependent protein kinase, glycogen synthase kinase 3, Ca2+/calmodulin-dependent protein kinase II, protein kinase C, and phosphorylase kinase phosphorylated the enzyme with a concomitant decrease in the activity ratio to values ranging from 0.1 to 0.4. Casein kinase II phosphorylated but did not inactivate glycogen synthase. Six tryptic phosphopeptides, obtained from heart glycogen synthase phosphorylated by the various kinases, were separated by reverse-phase chromatography. The phosphopeptide(s) obtained with each kinase eluted at the same position(s) as corresponding phosphopeptides obtained from rat skeletal muscle glycogen synthase. The study shows that the pattern of phosphorylation and effects on activity are very similar for cardiac and skeletal muscle glycogen synthase. It is suggested that the well known differences in heart and glycogen metabolism may be due to the interplay of kinases and phosphatases which could lead to different phosphorylation and activity states of glycogen synthase.
心肌糖原代谢的调控机制尚未完全明确。以往的研究表明,心脏糖原合酶在体内多个位点发生高度磷酸化。我们利用纯化的酶,研究了不同位点的磷酸化对大鼠心脏糖原合酶活性的影响。开发了一种简便的方法来纯化大鼠心脏糖原合酶。该酶经特定激酶磷酸化后,分析糖原合酶活性、磷酸化程度和磷酸肽图谱。纯化至表观均一性(SDS-PAGE上Mr为87,000)的大鼠心脏糖原合酶,其比活性为18 U/mg蛋白,活性比为0.74(无葡萄糖6-磷酸时的活性除以有葡萄糖6-磷酸时的活性)。环磷酸腺苷依赖性蛋白激酶、糖原合酶激酶3、Ca2+/钙调蛋白依赖性蛋白激酶II、蛋白激酶C和磷酸化酶激酶使该酶磷酸化,同时活性比降至0.1至0.4。酪蛋白激酶II使糖原合酶磷酸化但未使其失活。通过反相色谱法分离了由各种激酶磷酸化的心脏糖原合酶产生的六种胰蛋白酶磷酸肽。每种激酶产生的磷酸肽与从大鼠骨骼肌糖原合酶获得的相应磷酸肽在相同位置洗脱。该研究表明,心脏和骨骼肌糖原合酶的磷酸化模式及其对活性的影响非常相似。提示心脏和糖原代谢中众所周知的差异可能是由于激酶和磷酸酶的相互作用,这可能导致糖原合酶处于不同的磷酸化和活性状态。